International Assets Investment Management LLC purchased a new stake in shares of Smith & Nephew plc (NYSE:SNN – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 24,663 shares of the medical equipment provider’s stock, valued at approximately $792,000.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Lorne Steinberg Wealth Management Inc. increased its position in shares of Smith & Nephew by 53.6% during the second quarter. Lorne Steinberg Wealth Management Inc. now owns 231,045 shares of the medical equipment provider’s stock valued at $5,725,000 after buying an additional 80,650 shares during the period. Clearbridge Investments LLC purchased a new position in shares of Smith & Nephew during the first quarter valued at about $2,612,000. Sanctuary Advisors LLC purchased a new position in shares of Smith & Nephew during the second quarter valued at about $627,000. Tocqueville Asset Management L.P. increased its position in shares of Smith & Nephew by 294.9% during the first quarter. Tocqueville Asset Management L.P. now owns 224,441 shares of the medical equipment provider’s stock valued at $5,692,000 after buying an additional 167,599 shares during the period. Finally, Bank of Montreal Can increased its position in shares of Smith & Nephew by 355.8% during the second quarter. Bank of Montreal Can now owns 1,235,916 shares of the medical equipment provider’s stock valued at $31,059,000 after buying an additional 964,762 shares during the period. Hedge funds and other institutional investors own 25.64% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities research analysts have weighed in on SNN shares. Deutsche Bank Aktiengesellschaft cut shares of Smith & Nephew from a “buy” rating to a “hold” rating in a report on Friday, November 1st. StockNews.com upgraded shares of Smith & Nephew from a “buy” rating to a “strong-buy” rating in a report on Monday, August 5th.
Smith & Nephew Trading Up 1.1 %
Shares of SNN opened at $25.56 on Wednesday. The firm’s 50-day simple moving average is $29.75 and its two-hundred day simple moving average is $27.86. Smith & Nephew plc has a fifty-two week low of $23.65 and a fifty-two week high of $31.72. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51.
Smith & Nephew Profile
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
Featured Articles
- Five stocks we like better than Smith & Nephew
- What is a Death Cross in Stocks?
- Palantir Cracks $50, Is There Still Time to Get on Board?
- Market Cap Calculator: How to Calculate Market Cap
- Insider Buying Signals Upside for These 3 Stocks
- What are earnings reports?
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew plc (NYSE:SNN – Free Report).
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.